Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/13/2017 01/17/2017 01/18/2017 01/19/2017 01/20/2017 Date
23.82(c) 23.9(c) 23.92(c) 23.88(c) 23.9(c) Last
9 486 079 8 601 621 5 926 885 7 677 330 8 583 138 Volume
+1.28% +0.34% +0.08% -0.17% +0.08% Change
More quotes
Financials ($)
Sales 2016 8 354 M
EBIT 2016 1 982 M
Net income 2016 741 M
Debt 2016 4 735 M
Yield 2016 -
Sales 2017 8 781 M
EBIT 2017 2 180 M
Net income 2017 1 332 M
Debt 2017 2 705 M
Yield 2017 -
P/E ratio 2016 44,56
P/E ratio 2017 24,88
EV / Sales2016 4,46x
EV / Sales2017 4,01x
Capitalization 32 544 M
More Financials
Company
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in a broad range of interventional medical specialties.Its products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive,... 
More about the company
Surperformance© ratings of Boston Scientific Corporat
Trading Rating : Investor Rating :
More Ratings
Latest news on BOSTON SCIENTIFIC CORPORAT
01/21 BOSTON SCIENTIFIC : Large Inflow of Money Witnessed in Boston Scientific Corpora..
01/21 BOSTON SCIENTIFIC : $34,361 Federal Contract Awarded to Boston Scientific
01/20 BOSTON SCIENTIFIC CORP : Change in Directors or Principal Officers (form 8-K)
01/19 BOSTON SCIENTIFIC : Trademark Application for "DIRECTSENSE" Filed by Boston Scie..
01/19 BOSTON SCIENTIFIC : Joanna Engelke Joins Halloran Consulting Group as Managing D..
01/18 BOSTON SCIENTIFIC : Contract award - 65-- defibrillator-boston scientific
01/18 BOSTON SCIENTIFIC : $26,000 Federal Contract Awarded to Boston Scientific
01/10 CUTERA : Names James A. Reinstein as its Next President and CEO
01/10 BOSTON SCIENTIFIC : $26,500 Federal Contract Awarded to Boston Scientific
01/08DJCorrection to Parkinson's Therapy Story
More news
Sector news : Advanced Medical Equipment & Technology - NEC
01/19 Davos CEOs 'go local' on supply chain in Trump era
2016 Philips, Infineon lose appeal against EU cartel fines
2016 GRIFOLS : Spain's Grifols plans to refinance debt in first quarter 2017 after Ho..
2016 GRIFOLS : to buy Hologic's stake in blood screening JV for $1.85 billion
2016 Chinese bidders walk away from Osram takeover - sources
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on BOSTON SCIENTIFIC CORPORAT 
2012All technical elements to short
More Strategies
Latest Tweets
01/22$BSX - 18,099 Shares in Boston Scientific Corp. #BSX Acquired by Rothschild A.. 
01/17Boston Scientific Corporation upgraded by TheStreet to buy.  
01/13$BSX highs. Has had strong week
1
01/12Boston Scientific rises as CEO eases worry on growth prospects  
01/11$BSX lows after monster day yesterday 
More tweets
Qtime:92
News from SeekingAlpha
01/11 Boston Scientific (BSX) presents at 35th Annual J.P. Morgan Healthcare Confer..
01/10 Boston Sci expects to launch Lotus Edge heart valve in U.S. next year; shares..
2016 ABBOTT LABORATORIES : More Insiders Buy As Acquisition Uncertainties Likely To C..
2016 Neovasc Was Brilliant In Taking Advantage Of A Desperate Boston Scientific, B..
2016 Boston Scientific closes Neovasc transaction
Advertisement
Chart BOSTON SCIENTIFIC CORPORAT
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC...
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 27,4 $
Spread / Average Target 15%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Keith D. Dawkins Global Chief Medical Officer & Executive VP
Nelda J. Connors Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORP..10.49%32 544
THERMO FISHER SCIENTIF..1.71%56 690
DANAHER CORPORATION3.46%55 703
PHILIPS-3.72%27 770
INTUITIVE SURGICAL, IN..3.56%25 447
ILLUMINA, INC.24.76%23 466
More Results